These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8951480)

  • 1. [Radical prostatectomy for localized prostate cancer].
    Arakawa S; Hara I; Miyake H; Taguchi I; Yamada Y; Gotoh A; Ueno K; Matsui T; Fujisawa M; Eto H; Gohji K; Okada H; Kamidono S
    Hinyokika Kiyo; 1996 Oct; 42(10):811-5. PubMed ID: 8951480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of 15 years of radical prostatectomy].
    Frohmüller H; Theiss M; Wirth M; Hofmockel G
    Urologe A; 1995 May; 34(3):225-30. PubMed ID: 7610518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection].
    Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N
    Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of microinvasion of the capsule and/or micrometastasis of regional lymph nodes on disease free survival after radical prostatectomy.
    Hering F; Schmid HP; Graber P
    Ann Urol (Paris); 1994; 28(4):196-201. PubMed ID: 7979209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
    Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
    J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of localized prostate cancer: radical prostatectomy versus radiation therapy].
    Kanamaru H; Akino H; Mori H; Okada K; Arai Y
    Hinyokika Kiyo; 1996 Oct; 42(10):817-20. PubMed ID: 8951481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy.
    Fujita K; Nakayama M; Nakai Y; Takayama H; Nishimura K; Ujike T; Nishimura K; Aozasa K; Okuyama A; Nonomura N
    Cancer Sci; 2009 Jun; 100(6):1047-50. PubMed ID: 19385972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Bader P; Burkhard FC; Markwalder R; Studer UE
    J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
    Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
    Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.